“`html
Wave Life Sciences Ltd (WVE) shares have surpassed the average analyst 12-month target price of $19.80, currently trading at $21.31. This shift prompts potential analyst reactions, which may include downgrading the stock’s valuation or raising the target price to reflect the recent gains.
Within the Zacks coverage universe, there are 15 different analyst targets for WVE, ranging from a low of $9.00 to a high of $36.00, with a standard deviation of $6.667. Currently, the consensus ratings include 13 Strong Buy, 1 Buy, and 2 Hold, with no Sell or Strong Sell ratings, resulting in an average rating of 1.31 on a scale where 1 is Strong Buy and 5 is Strong Sell.
“`
